This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Elsevier And Kitware Bring 3D Visualization Tools And Techniques To ScienceDirect

About Kitware

Kitware is a leader in the creation and support of open-source software and state-of-the-art technology, and is one of the fastest growing software companies in the country. Kitware's mission is to develop and deliver cutting-edge software products and services utilizing advanced software quality methods and technologies. Since its founding in 1998, Kitware has combined an open-source business model with state-of-the-art software engineering and world-class imaging expertise to become the industry leader in open-source solutions for medical computing, scientific computing, computer vision, data management, and quality software process. The company's business model is anchored on improving open-source platforms unfettered by intellectual property restrictions, while generating profit by providing consulting services to a diverse set of scientific and engineering communities. This model has proven highly successful and resilient even in the face of the most recent global recession.

Kitware has built a strong reputation by partnering with government, academic, and commercial organizations to create and support large, collaborative, and open-source communities that use, improve, and nurture a common software platform. The company has maintained decade-long open-source collaborations with prestigious organizations such as Los Alamos National Laboratory, Sandia National Laboratories, the National Science Foundation (NSF), and the National Library of Medicine (NLM). This has resulted in some of the largest and most successful open-source, community-driven software engineering projects, including the Visualization Toolkit (VTK), the Insight Segmentation and Registration Toolkit (ITK), ParaView, and the cross-platform build tool CMake. Kitware also provides a significant amount of software development services to large and small commercial customers interested in leveraging and engaging with open-source communities. This includes medical device manufacturers, pharmaceutical companies, and the oil and gas industry.

About ScienceDirect

ScienceDirect is home to almost one-quarter of the world's peer-reviewed full-text scientific, technical and medical content. Over 15 million researchers, health care professionals, teachers, students and information professionals around the globe rely on ScienceDirect as a trusted source of nearly 2,200 journals, almost 900 serials and close to 22,000 book titles. ScienceDirect supports research and education with interactive elements in articles such as audio, video, graphs, tables and images, and offers tools so users can easily set alerts. Content on ScienceDirect also features embedded links to external datasets, including earth and environmental science data from PANGAEA, abstract and indexing data from Scopus and chemical reactions data from Reaxys. With almost 12 million content pieces available-including pre-publication release of articles and open access content from Elsevier journals-ScienceDirect is a premier platform for discovering the world of research.

About Elsevier

3 of 4

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,909.58 -5.49 -0.03%
S&P 500 1,964.12 -0.56 -0.03%
NASDAQ 4,406.99 +10.7860 0.25%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs